Table 1.
Demographic and clinical characteristics of hcc cases and non-hcc controls
| Median (Inter-quartile range) or N (%) | *p-value | ||
|---|---|---|---|
| Variables | HCC (n = 62) | Non-HCC (n = 57) | |
| Age (years) | 49.5(35–55) | 36(32–51) | p = 0.05 |
| Gender M:F | 48:14 | 38:19 | p = 0.19 |
| AST (u/L) | 89(68–112) | 12(7–23) | p < 0.001 |
| ALT (u/L) | 36(22–54) | 8(5–16) | p < 0.001 |
| Total Bilirubin (μmol/l) | 60.3(28–144) | 18(11.1-29) | p < 0.001 |
| Albumin (g/l) | 30(26–35) | 36(34–39) | p < 0.001 |
| INR | 1.19(1–1.4) | 1.1(1–1.2) | p = 0.22 |
| Positive for HBsAg | 41(66.1 %) | 42(73.7 %) | p = 0.52 |
| Positive for Anti-HCV | 0 %) | 1(1.8 %) | p = 0.30 |
*P value <0.05 is deemed significant
AST aspartate transaminase, HBsAg Hepatitis B surface antigen, ALT alanine transaminase, Anti-HCV Hepatitis C antibody